Main Points:
– A clinical trial for a Lassa fever vaccine has started enrolling participants at the University of Maryland School of Medicine.
– Lassa fever can lead to a severe hemorrhagic disease and outbreaks are increasingly common in parts of West Africa.
Author’s Take:
The initiation of a clinical trial for a Lassa fever vaccine at the University of Maryland School of Medicine represents a significant milestone in the fight against this dangerous disease. With outbreaks on the rise in certain areas of West Africa, the development of a vaccine could be crucial in preventing future epidemics and protecting public health.
Click here for the original article.